Last reviewed · How we verify
Placebo administered by Magnair
Placebo produces no pharmacological effect and serves as a control comparator in clinical trials.
Placebo produces no pharmacological effect and serves as a control comparator in clinical trials. Used for Control comparator in respiratory clinical trials.
At a glance
| Generic name | Placebo administered by Magnair |
|---|---|
| Sponsor | Sunovion Respiratory Development Inc. |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance administered to control groups in clinical studies to account for the placebo effect and natural disease progression. It allows researchers to isolate the true therapeutic benefit of an active drug by comparing outcomes between placebo and active treatment groups. The Magnair delivery device is used to administer the placebo in a manner consistent with how active respiratory medications would be delivered.
Approved indications
- Control comparator in respiratory clinical trials
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: